ChemImpex Meclizine dihydrochloride; 98% (HPLC); 1104-22-9; MFCD00058199, 5G

Meclizine dihydrochloride is a well-established antihistamine primarily used for the prevention and treatment of motion sickness and vertigo. This compound is recognized for its ability to effectively reduce nausea and dizziness associated with these conditions, making it a valuable asset in both clinical and over-the-counter applications. Its unique structure allows for a prolonged duration of action, providing relief for patients during travel or in situations that may induce motion-related discomfort.

In addition to its primary use in treating motion sickness, Meclizine dihydrochloride has been explored for its potential benefits in managing symptoms of vestibular disorders and as an adjunct therapy in certain neurological conditions. Researchers appreciate its favorable safety profile and efficacy, which make it a preferred choice in various therapeutic settings. The compounds versatility and effectiveness in alleviating discomfort highlight its significance in both pharmaceutical formulations and clinical practice.

Specifications

Safety & Regulations